These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35742735)

  • 1. Prevalence, Features and Degree of Association of Oral Lesions in COVID-19: A Systematic Review of Systematic Reviews.
    Di Spirito F; Iandolo A; Amato A; Caggiano M; Raimondo A; Lembo S; Martina S
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of oral manifestations in COVID-19: A systematic review.
    Sharma P; Malik S; Wadhwan V; Gotur Palakshappa S; Singh R
    Rev Med Virol; 2022 Nov; 32(6):e2345. PubMed ID: 35271738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.
    Casillas Santana MA; Arreguín Cano JA; Dib Kanán A; Dipp Velázquez FA; Munguía PDCS; Martínez Castañón GA; Castillo Silva BE; Sámano Valencia C; Salas Orozco MF
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and Oral Mucosal Lesions: a Systematic Review.
    Pergolini D; Graniero F; Magnifico L; Migliau G; Rocchetti F; Mohsen A; Tenore G; Romeo U; Palaia G
    Clin Ter; 2023; 174(6):550-563. PubMed ID: 38048120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and Related Vaccinations in Children: Pathogenic Aspects of Oral Lesions.
    Di Spirito F; D'Ambrosio F; Di Palo MP; Giordano F; Coppola N; Contaldo M
    Children (Basel); 2023 Apr; 10(5):. PubMed ID: 37238357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Manifestations of COVID-19 in Hospitalized Patients: A Systematic Review.
    Orilisi G; Mascitti M; Togni L; Monterubbianesi R; Tosco V; Vitiello F; Santarelli A; Putignano A; Orsini G
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral mucosal lesions in patients with SARS-CoV-2 infection. Report of four cases. Are they a true sign of COVID-19 disease?
    Cruz Tapia RO; Peraza Labrador AJ; Guimaraes DM; Matos Valdez LH
    Spec Care Dentist; 2020 Nov; 40(6):555-560. PubMed ID: 32882068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 manifestation in the oral cavity - a narrative literature review.
    Kusiak A; Cichońska D; Tubaja M; Skorek A; Jereczek-Fossa BA; Corrao G; Marvaso G; Alterio D
    Acta Otorhinolaryngol Ital; 2021 Oct; 41(5):395-400. PubMed ID: 34734574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Manifestations in Patients with COVID-19: A 6-Month Update.
    Amorim Dos Santos J; Normando AGC; Carvalho da Silva RL; Acevedo AC; De Luca Canto G; Sugaya N; Santos-Silva AR; Guerra ENS
    J Dent Res; 2021 Nov; 100(12):1321-1329. PubMed ID: 34324825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Determinants of Immediate and Long-Term PTSD Consequences of Coronavirus-Related (CoV-1 and CoV-2) Pandemics among Healthcare Professionals: A Systematic Review and Meta-Analysis.
    Al Falasi B; Al Mazrouei M; Al Ali M; Al Dhamani M; Al Ali A; Al Kindi M; Dalkilinc M; Al Qubaisi M; Campos LA; Al Tunaiji H; Baltatu OC
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33672257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and oral diseases: Assessing manifestations of a new pathogen in oral infections.
    Naqvi AR; Schwartz J; Brandini DA; Schaller S; Hussein H; Valverde A; Naqvi RA; Shukla D
    Int Rev Immunol; 2022; 41(4):423-437. PubMed ID: 34525891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual transmission of SARS-CoV-2 virus and its role in the spread of COVID-19: A living systematic review protocol.
    Duarte G; Ortiz-Muñoz L; Morales MB; Acuña MP; Rada G;
    Medwave; 2020 Nov; 20(10):e8062. PubMed ID: 33361754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral manifestations in SARS-CoV-2 infection.
    Tuter G; Yerebakan M; Celik B; Kara G
    Med Oral Patol Oral Cir Bucal; 2022 Jul; 27(4):e330-e339. PubMed ID: 35717616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is SARS-CoV-2 an Etiologic Agent or Predisposing Factor for Oral Lesions in COVID-19 Patients? A Concise Review of Reported Cases in the Literature.
    Etemad-Moghadam S; Alaeddini M
    Int J Dent; 2021; 2021():6648082. PubMed ID: 34054961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis.
    Ng WH; Tipih T; Makoah NA; Vermeulen JG; Goedhals D; Sempa JB; Burt FJ; Taylor A; Mahalingam S
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.